Stuart S, Tarade D, Ohh M
Sci Rep. 2024; 14(1):14799.
PMID: 38926538
PMC: 11208597.
DOI: 10.1038/s41598-024-65537-9.
Falke S, Lieske J, Herrmann A, Loboda J, Karnicar K, Gunther S
J Med Chem. 2024; 67(9):7048-7067.
PMID: 38630165
PMC: 11089505.
DOI: 10.1021/acs.jmedchem.3c02351.
Hartley B, Bassiouni W, Schulz R, Julien O
Basic Res Cardiol. 2023; 118(1):38.
PMID: 37768438
DOI: 10.1007/s00395-023-01007-z.
Yang W, Li Q, Sun J, Huat Tan S, Tang Y, Zhao M
Comput Struct Biotechnol J. 2022; 20:2442-2454.
PMID: 35602976
PMC: 9110316.
DOI: 10.1016/j.csbj.2022.05.023.
Sarkar A, Mandal K
Angew Chem Int Ed Engl. 2021; 60(44):23492-23494.
PMID: 34545983
PMC: 8652770.
DOI: 10.1002/anie.202107481.
Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation.
Ledwon P, Papini A, Rovero P, Latajka R
Materials (Basel). 2021; 14(12).
PMID: 34200889
PMC: 8230458.
DOI: 10.3390/ma14123217.
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease.
Milligan J, Zeisner T, Papageorgiou G, Joshi D, Soudy C, Ulferts R
Biochem J. 2021; 478(13):2499-2515.
PMID: 34198327
PMC: 8286836.
DOI: 10.1042/BCJ20210197.
SARS-CoV-2 M: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors.
Citarella A, Scala A, Piperno A, Micale N
Biomolecules. 2021; 11(4).
PMID: 33921886
PMC: 8073203.
DOI: 10.3390/biom11040607.
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease.
Gunther S, Reinke P, Fernandez-Garcia Y, Lieske J, Lane T, Ginn H
Science. 2021; 372(6542):642-646.
PMID: 33811162
PMC: 8224385.
DOI: 10.1126/science.abf7945.
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses.
Hu Y, Ma C, Szeto T, Hurst B, Tarbet B, Wang J
ACS Infect Dis. 2021; 7(3):586-597.
PMID: 33645977
PMC: 7944397.
DOI: 10.1021/acsinfecdis.0c00761.
Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development.
Liu C, Boland S, Scholle M, Bardiot D, Marchand A, Chaltin P
Antiviral Res. 2021; 187:105020.
PMID: 33515606
PMC: 7839511.
DOI: 10.1016/j.antiviral.2021.105020.
Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CL Inhibitors.
Rawson J, Duchon A, Nikolaitchik O, Pathak V, Hu W
Viruses. 2021; 13(2).
PMID: 33498923
PMC: 7911889.
DOI: 10.3390/v13020173.
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M and cathepsin L.
Sacco M, Ma C, Lagarias P, Gao A, Townsend J, Meng X
Sci Adv. 2020; 6(50).
PMID: 33158912
PMC: 7725459.
DOI: 10.1126/sciadv.abe0751.
Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture.
Hu Y, Ma C, Szeto T, Hurst B, Tarbet B, Wang J
bioRxiv. 2020; .
PMID: 33140049
PMC: 7605558.
DOI: 10.1101/2020.10.30.362335.
Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M and cathepsin L.
Sacco M, Ma C, Lagarias P, Gao A, Townsend J, Meng X
bioRxiv. 2020; .
PMID: 32766590
PMC: 7402059.
DOI: 10.1101/2020.07.27.223727.
Cathepsin B Dependent Cleavage Product of Serum Amyloid A1 Identifies Patients with Chemotherapy-Related Cardiotoxicity.
Zhang F, Lyon C, Walls R, Ning B, Fan J, Hu T
ACS Pharmacol Transl Sci. 2020; 2(5):333-341.
PMID: 32259067
PMC: 7089022.
DOI: 10.1021/acsptsci.9b00035.
Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.
Matos A, Pinto F, Barros P, Amaral M, Pepperkok R, Matos P
J Biol Chem. 2019; 294(36):13396-13410.
PMID: 31324722
PMC: 6737230.
DOI: 10.1074/jbc.RA119.008738.
DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B.
Yousefelahiyeh M, Xu J, Alvarado E, Yu Y, Salven D, Nissen R
PLoS One. 2018; 13(11):e0207779.
PMID: 30496304
PMC: 6264848.
DOI: 10.1371/journal.pone.0207779.
Alteration of Androgen Receptor Protein Stability by Triptolide in LNCaP Cells.
Li W, Liu B, Liao K, Liu Y, Wan Z, Dong Y
Medicina (Kaunas). 2018; 54(3).
PMID: 30344270
PMC: 6122114.
DOI: 10.3390/medicina54030039.
Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage.
Scott I, Majithiya J, Sanden C, Thornton P, Sanders P, Moore T
Sci Rep. 2018; 8(1):3363.
PMID: 29463838
PMC: 5820248.
DOI: 10.1038/s41598-018-21589-2.